Exploring the 15-year journey of the Affordable Care Act, its impact on U.S. health insurance, and future challenges as subsidies near expiration in 2025.

President Trump's executive order delays Medicare drug price negotiations, favoring pharmaceutical companies and potentially increasing drug costs for the public.

Explore significant updates in the U.S. insurance industry related to prior authorization, including federal and state legislative shifts, and the deployment of AI technology.

Explore the new executive order signed by President Trump aimed at reducing drug prices and improving Medicare transparency. Understand its impact on healthcare costs and policy continuity in U.S. healthcare.

Explore the complexities of Colorado's Medicaid funding structure and its implications for state health coverage, including FMAP discrepancies among populations.

President Trump signs an executive order to lower U.S. prescription drug prices, amending key Medicare negotiations. Learn how this could impact the healthcare and insurance sectors.

Exploring the challenges faced by rural hospitals with Medicare Advantage contracts, including lower reimbursement rates and resource-intensive administrative processes.

CMS has announced a significant 5.06% payment increase for Medicare Advantage plans for 2026, improving financial support amidst rising healthcare costs.

MedPAC estimates that Medicare Advantage costs will exceed traditional Medicare by $84 billion, affecting future healthcare policy.

Discover the growing physician shortage crisis in the U.S. and proposed solutions for healthcare reform.